SteadyMed sets the terms for its pending initial public offering, which would bring in $55 million if priced at the midpoint of the range.
SteadyMed Therapeutics yesterday set the terms for its pending debut on the public market, saying it plans to float 4.25 million shares at $12 to $14 apiece.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1FGz3Vj
Cap comentari:
Publica un comentari a l'entrada